| Citation: | MENG Shasha, LI Nan, LIU Xiaohua. The expression of NLPR3 and NF-κB in peripheral blood mononuclear cells of patients with diabetic cardiomyopathy and their correlation with myocardial perfusion[J]. Chinese Journal of General Practice, 2025, 23(10): 1681-1684. doi: 10.16766/j.cnki.issn.1674-4152.004204 |
| [1] |
于向慧, 和欢, 张茹, 等. 凝集素样氧化低密度脂蛋白受体1基因敲除对糖尿病性心肌病保护作用的研究[J]. 中国糖尿病杂志, 2022, 30(12): 925-933.
YU X H, HE H, ZHANG R, et al. Study on the protective effect of lectin-like oxidized low-density lipoprotein receptor 1 gene knockout in diabetic cardiomyopathy[J]. Chin J Diabetes, 2022, 30(12): 925-933.
|
| [2] |
王毅, 尤红俊, 韩稳琦, 等. 糖尿病性心肌病小鼠心肌线粒体circRNA表达谱与功能富集分析[J]. 西安交通大学学报: 医学版, 2023, 44(5): 701-708.
WANG Y, YOU H J, HAN W Q, et al. Analysis of circRNA expression profile and functional enrichment of myocardial mitochondria in mice with diabetic cardiomyopathy[J]. J Xi'an Jiaotong Univ (Med Sci), 2023, 44(5): 701-708.
|
| [3] |
张花治, 金智生, 孙金宁, 等. 红芪多糖对db/db小鼠糖尿病心肌病NF-κB/IKKβ信号通路的影响[J]. 中国临床药理学杂志, 2024, 40(6): 849-853.
ZHANG H Z, JIN Z S, SUN J N, et al. Effects of Hedysarum polybotrys polysacchcaide on NF-κB/IKKβ signaling pathway in db/db mice with diabetic cardiomyopathy[J]. Chin J Clin Pharmacol, 2024, 40(6): 849-853.
|
| [4] |
刘晨阳, 杨海晨, 耿嘉逸, 等. NLRP3和白细胞介素6受体与房颤相关性研究[J]. 蚌埠医学院学报, 2024, 49(1): 23-27.
LIU C Y, YANG H C, GENG J Y, et al. Correlation between NLRP3, IL-6R and atrial fibrillation[J]. J Bengbu Med Coll, 2024, 49(1): 23-27.
|
| [5] |
刘一潼, 周穗子, 邱前辉. NLRP3炎症小体在慢性鼻窦炎和变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 142-146, 153.
LIU Y T, ZHOU S Z(review), QIU Q H(checking). Research progress on NLRP3 inflammasome in chronic rhinosinusitis and allergic rhinitis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2022, 36(3): 142-146, 153.
|
| [6] |
HAO J J, ZHOU J D, HU S Q, et al. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation[J]. Am J Physiol Cell Physiol, 2024, 326(2): C331-C347. doi: 10.1152/ajpcell.00467.2023
|
| [7] |
SUN Q, GUO W X, YUE T, et al. NLRP3 inflammasome mechanism and therapeutic targets in diabetic cardiomyopathy[J]. Gac Med Mex, 2023, 159(3): 255-261.
|
| [8] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344.
Diabetes society of Chinese medical association. Chinese guidelines for the prevention and treatment of type 2 diabetes (2017 edition)[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(4): 292-344.
|
| [9] |
朱雅倩, 胡高超, 瞿星光. 血清炎症因子在糖尿病性心肌病患者中的表达及其对心肌细胞线粒体功能的影响[J]. 实用临床医药杂志, 2022, 26(24): 57-60, 85.
ZHU Y Q, HU G C, QU X G. Expression of serum inflammatory cytokines in patients with diabetic cardiomyopathy and their effects on mitochondrial function of cardiomyocytes[J]. J Clin Med Pract, 2022, 26(24): 57-60, 85.
|
| [10] |
曹丽慧, 孟宪杰, 李会. 外周血miR-4465和miR-6089在亚临床糖尿病性心肌病诊断中的价值[J]. 中南医学科学杂志, 2024, 52(1): 91-93, 105.
CAO L H, MENG X J, LI H. Analysis of value of peripheral blood miR-4465 and miR-609 detection in the diagnosis of sub-clinical disease progression[J]. Med Sci J Central South Chin, 2024, 52(1): 91-93, 105.
|
| [11] |
崔艺璇, 周翔, 刘宽, 等. 瞬时受体电位通道蛋白5对糖尿病性心肌病炎症的调节作用[J]. 中国药理学通报, 2022, 38(2): 201-208.
CUI Y X, ZHOU X, LIU K, et al. Regulation of transient receptor potential channel protein 5 in inflammation in diabetic cardiomyopathy[J]. Chin Pharmacol Bull, 2022, 38(2): 201-208.
|
| [12] |
林小淇, 邱晓拂, 袁雪峰, 等. 炎症小体NLRP3调控LPS诱导的前列腺癌增殖和侵袭的机制研究[J]. 解剖学研究, 2022, 44(6): 544-550.
LIN X Q, QIU X F, YUAN X F, et al. The mechanisms of the regulation of NLRP3 inflammasome on prostate cacner cells proliferation and invasion[J]. Anatomy Res, 2022, 44(6): 544-550.
|
| [13] |
沈子豪, 黄益桃, 游伊珺, 等. 基于PI3K/Akt、NF-κB信号通路探讨中医药防治心肌缺血再灌注损伤的机制[J]. 实用心脑肺血管病杂志, 2023, 31(12): 36-42.
SHEN Z H, HUANG Y T, YOU Y J, et al. Mechanism of Traditional Chinese Medicine in Preventing and Treating Myocardial Ischemia-Reperfusion Injury Based on the PI3K/Akt, NF-κB Signaling Pathway[J]. Journal of Practical Cardiovascular and Pulmonary Diseases, 2023, 31(12): 36-42.
|
| [14] |
李效丽, 王涛, 董传芳, 等. 水苏碱调节HIF-1α/NLRP3信号通路对缺氧/复氧诱导的心肌细胞焦亡的影响[J]. 中国药学杂志, 2024, 59(24): 2337-2342.
LI X L, WANG T, DONG C F, et al. Effect of hydrostachyline modulating HIF-1α/NLRP3 signaling pathway on hypoxia/reoxygenation-induced pyroptosis of cardiomyocytes[J]. Chin Pharma J, 2024, 59(24): 2337-2342.
|
| [15] |
王金鑫, 饶春晖, 代波, 等. 绿原酸通过TLR4/NF-κB信号通路调控脓毒症大鼠肠上皮细胞屏障功能的研究[J]. 中华全科医学, 2023, 21(3): 405-408. doi: 10.16766/j.cnki.issn.1674-4152.002894
WANG J X, RAO C H, DAI B, et al. Chlorogenic acid effects of intestinal epithelial barrier function with septic rats through TLR4/NF-κB signaling pathway[J]. Chinese Journal of General Practice, 2023, 21(3): 405-408. doi: 10.16766/j.cnki.issn.1674-4152.002894
|
| [16] |
姜一凡, 李小荣, 耿嘉逸, 等. 槲皮素通过抑制HMGB1/RAGE/NF-κB信号通路减轻糖尿病引起的大鼠肾脏损伤[J]. 南方医科大学学报, 2024, 44(9): 1769-1775.
JIANG Y F, LI X R, GENG J Y, et al. Quercetin ameliorates diabetic kidney injury in rats by inhibiting the HMGB1/RAGE/NF-κB signaling pathway[J]. J South Med Univ, 2024, 44(9): 1769-1775.
|
| [17] |
ZHANG L X, AI C C, BAI M, et al. NLRP3 inflammasome/pyroptosis: a key driving force in diabetic cardiomyopathy[J]. Int J Mol Sci, 2022, 23(18). DOI: 10.3390/ijms231810632.
|
| [18] |
张赛, 陈正涛, 唐诗韵, 等. NLRP3炎症小体与糖尿病心肌病的关系及中医药调控研究进展[J]. 中国实验方剂学杂志, 2023, 29(16): 250-263.
ZHANG S, CHEN Z T, TANG S Y, et al. Relationship Between NLRP3 Inflammasome and Diabetic Cardiomyopathy and Intervention Effect of Traditional Chinese Medicine: A Review[J]. Chin J Exp Tradit Med Formulae, 2023, 29(16): 250-263.
|
| [19] |
孙文娟, 孙永红. NF-κB信号通路在儿童川崎病心脏损伤中的研究进展[J]. 中国当代儿科杂志, 2023, 25(3): 250-252.
SUN W J, SUN Y H. Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease[J]. Chin J Contemp Pediatr, 2023, 25(3): 250-252.
|
| [20] |
李利超, 王少博, 程艳, 等. miR-22-3p靶向NLRP3表达对脑缺血再灌注损伤大鼠细胞焦亡的影响[J]. 中国免疫学杂志, 2023, 39(7): 1402-1408.
LI L C, WANG S B, CHENG Y, et al. Effect of miR-22-3p on pyroptosis of cerebral ischemia-reperfusion injury rats via targeting expression of NLRP3[J]. Chin J Immunol, 2023, 39(7): 1402-1408.
|